175 related articles for article (PubMed ID: 33867441)
1. Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease.
Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e529-e534. PubMed ID: 33867441
[TBL] [Abstract][Full Text] [Related]
2. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
3. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
[TBL] [Abstract][Full Text] [Related]
5. Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study.
Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
Eur J Endocrinol; 2019 Aug; 181(2):185-192. PubMed ID: 31176297
[TBL] [Abstract][Full Text] [Related]
6. Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease.
Kim HY; Baik SJ; Lee HA; Lee BK; Lee HS; Kim TH; Yoo K
Sci Rep; 2020 Oct; 10(1):17491. PubMed ID: 33060775
[TBL] [Abstract][Full Text] [Related]
7. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
[TBL] [Abstract][Full Text] [Related]
9. Lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes mellitus: A literature review and meta-analysis.
Gao Y; Zhao T; Song S; Duo Y; Gao J; Yuan T; Zhao W
Diabetes Res Clin Pract; 2023 Jun; 200():110699. PubMed ID: 37169306
[TBL] [Abstract][Full Text] [Related]
10. Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals.
Kim NH; Kang JH; Kim HJ
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):945-951. PubMed ID: 38652507
[TBL] [Abstract][Full Text] [Related]
11. Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects.
Feldman A; Wernly B; Strebinger G; Eder SK; Zandanell S; Niederseer D; Strasser M; Haufe H; Sotlar K; Paulweber B; Datz C; Aigner E
J Gastrointestin Liver Dis; 2021 Sep; 30(3):366-373. PubMed ID: 34375373
[TBL] [Abstract][Full Text] [Related]
12. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study.
Ahmed OT; Gidener T; Mara KC; Larson JJ; Therneau TM; Allen AM
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1374-1381.e6. PubMed ID: 34265444
[TBL] [Abstract][Full Text] [Related]
13. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
15. Muscle strength, but not body mass index, is associated with mortality in patients with non-alcoholic fatty liver disease.
Charatcharoenwitthaya P; Karaketklang K; Aekplakorn W
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2393-2404. PubMed ID: 36017777
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic Fatty Liver Disease and Risk of Early-Onset Vasomotor Symptoms in Lean and Overweight Premenopausal Women.
Cho Y; Chang Y; Choi HR; Kang J; Kwon R; Lim GY; Ahn J; Kim KH; Kim H; Hong YS; Zhao D; Rampal S; Cho J; Park HY; Guallar E; Ryu S
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889762
[TBL] [Abstract][Full Text] [Related]
17. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
[TBL] [Abstract][Full Text] [Related]
18. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
Kimura T; Deshpande GA; Urayama KY; Masuda K; Fukui T; Matsuyama Y
J Gastroenterol Hepatol; 2015 May; 30(5):909-17. PubMed ID: 25469977
[TBL] [Abstract][Full Text] [Related]
19. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.
Tang A; Ng CH; Phang PH; Chan KE; Chin YH; Fu CE; Zeng RW; Xiao J; Tan DJH; Quek J; Lim WH; Mak LY; Wang JW; Chew NWS; Syn N; Huang DQ; Siddiqui MS; Sanyal A; Muthiah M; Noureddin M
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1750-1760.e12. PubMed ID: 35863685
[TBL] [Abstract][Full Text] [Related]
20. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
